Layer, Chiang, et al. Genome Biology
Quark to File IND for Eye Disease Rx in September; New Data Shows It May Treat Glaucoma
The drug's initial indication will be non-arteritic anterior ischemic optic neuropathy, a rare condition that can lead to permanent blindness, but the company expects to ultimately develop it as glaucoma therapy.
New to GenomeWeb? Register here quickly.